About Careers MedBlog Contact us

US FDA Approves Neupogen as The First Drug To Treat Sickness Due to Radiation Exposure

by Julia Samuel on May 23, 2015 at 3:30 PM
Font : A-A+

US FDA Approves Neupogen as The First Drug To Treat Sickness Due to Radiation Exposure

US Food and Drug Administration (FDA) has approved a drug to treat the deleterious effects of radiation exposure following a nuclear incident. Originally, the drug was used to treat side effects of chemotherapy.

The drug, Neupogen, is the first ever approved for the treatment of acute radiation injury and the approval came as a result of research performed by the University of Maryland School of Medicine (UM SOM) scientists, claims a study.


The investigators did their research in a non-human clinical model of high-dose radiation.

"Our research shows that this drug works to increase survival by protecting blood cells. That is a significant advancement, because the drug can now be used as a safe and effective treatment for the blood cell effects of severe radiation poisoning," said Thomas MacVittie, one of the researchers.

Radiation damages the bone marrow, and as a result decreases production of infection-fighting white blood cells. Neupogen counteracts these effects.

The drug, which is made by Amgen Inc., was first approved in 1991 to treat cancer patients receiving chemotherapy.

Although doctors may use it "off label" for other indications, the research and the resulting approval would speed up access to and use of the drug in the event of a nuclear incident, the study noted.

The research builds on 40 years of work that MacVittie and his team have conducted in the field of radiation research, during which they have helped to define the field.

Source: Medindia


Recommended Reading

Latest Research News

What Are the Effects of T Cells on Blood Pressure and Inflammation?
A new study explored the link between T immune cells in ill patients and mortality risk.
How Does a New Procedure Help Patients Avoid Leg Amputation?
Limb savage procedure benefits patients with severe vascular disease who are at risk for amputation of their limbs.
Omega-3 Can Save Alzheimer's Patients from Vision Loss
Does omega-3 help Alzheimer's patients? A new form of omega-3 helped restore specific markers of eye health in mice bred with aspects of early-onset Alzheimer's disease.
Why Is Asthma Linked to Increased Risk of Osteoarthritis?
Drugs used to inhibit the physiological responses for allergic reactions lessen osteoarthritis risk, revealed research.
 Experiments on Child Brain Tumour and Muscle Ageing Heading to Space
The International Space Station will be used to carry out experiments seeking to improve understanding of incurable child brain tumors and the muscle aging process.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

US FDA Approves Neupogen as The First Drug To Treat Sickness Due to Radiation Exposure Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests